Trump seeks to lower drugmakers’ Medicaid prices: 5 notes 

(By: Alexandra Murphy for Becker’s Hospital Review)

President Donald Trump is targeting the pharmaceutical industry as a way to help finance his tax cut plans, pressing House Republicans to force drugmakers to accept lower prices on drugs covered by Medicaid, Bloomberg reported May 2. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.